GLP-1 agonists have shown promising effects on menstrual cycle regularity, particularly in women with PCOS. Research indicates that these medications can help restore regular ovulation, which is often disrupted in women with PCOS due to hormonal imbalances.
Patients undergoing treatment with GLP-1 agonists require close monitoring for potential adverse effects induced by the medication. GLP-1RAs do not increase the risk of hypoglycemia but exhibit a good safety profile and are generally well tolerated in PCOS management [70].
Understanding GLP-1 Agonists: A Comprehensive Guide. Part 1: The Evolution From Diabetes Treatment to Weight Loss. "Going on a medication for weight loss is NOT the easy way out." - Dr. Ali. Detailed Synopsis.
Natural and Oral GLP-1 Agonists: Expanding Your Treatment Options. While synthetic GLP-1 agonists are widely prescribed, natural methods like a fiber-rich diet, regular exercise, and adequate sleep can also boost GLP-1 levels.
More research is needed to understand the effects of Ozempic and other GLP-1 agonists on people with eating disorders, including the potential of the drugs to treat binge eating disorder.
A narrative review was conducted using PubMed/MEDLINE, through May 2025, to examine GLP-1RA effects on BED, including preclinical and clinical studies, mechanistic investigations, and relevant reviews.
Weight Loss: Patients treated with GLP-1 agonists often experience significant reductions in body weight compared to those receiving placebo or other treatments. The weight loss is primarily attributed to reduced calorie intake, enhanced satiety, and potential changes in metabolic rate.
:max_bytes(150000):strip_icc()/HDC-GettyImages-2195485788-299e147644524b339a084114355dff83.jpg "Image result for GLP-1 agonist treatment and cortisol narrative")
